Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report)'s stock had its "sell (d-)" rating restated by investment analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.
Monogram Orthopaedics Price Performance
Shares of NASDAQ:MGRM opened at $6.00 on Wednesday. The firm's 50-day simple moving average is $5.69 and its 200-day simple moving average is $4.03. Monogram Orthopaedics has a fifty-two week low of $1.92 and a fifty-two week high of $6.43. The company has a market cap of $243.79 million, a price-to-earnings ratio of -12.00 and a beta of 0.68.
Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last posted its quarterly earnings results on Friday, August 15th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.05). On average, research analysts forecast that Monogram Orthopaedics will post -0.49 EPS for the current year.
Institutional Trading of Monogram Orthopaedics
Several large investors have recently bought and sold shares of the company. Orion Porfolio Solutions LLC increased its stake in shares of Monogram Orthopaedics by 15.4% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 13,850 shares of the company's stock worth $40,000 after purchasing an additional 1,850 shares in the last quarter. Crestwood Advisors Group LLC acquired a new stake in Monogram Orthopaedics during the 2nd quarter valued at $29,000. Jane Street Group LLC grew its holdings in Monogram Orthopaedics by 83.0% during the 1st quarter. Jane Street Group LLC now owns 19,426 shares of the company's stock valued at $57,000 after buying an additional 8,810 shares during the last quarter. Finally, Focus Partners Advisor Solutions LLC increased its position in Monogram Orthopaedics by 6.1% during the first quarter. Focus Partners Advisor Solutions LLC now owns 213,678 shares of the company's stock worth $628,000 after buying an additional 12,328 shares in the last quarter. Institutional investors and hedge funds own 0.45% of the company's stock.
About Monogram Orthopaedics
(
Get Free Report)
Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Monogram Orthopaedics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monogram Orthopaedics wasn't on the list.
While Monogram Orthopaedics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
